Altimmune, Inc

(NASDAQ:ALT)

Latest On Altimmune, Inc (ALT):

Date/Time Type Description Signal Details
2023-05-11 16:23 ESTNewsAltimmune GAAP EPS of -$0.40 beats by $0.08N/A
2023-05-11 16:22 ESTNewsAltimmune, Inc. (ALT) Q1 2023 Earnings Call TranscriptN/A
2023-05-10 12:33 ESTNewsAltimmune: A Story, It Seems, Of Too Little Too LateN/A
2023-03-22 23:18 ESTNewsAltimmune hits 10-month low as Goldman Sachs downgrades on weight loss dataN/A
2023-03-21 16:21 ESTNewsAltimmune stock slumps ~35% amid phase 2 trial data of obesity drug pemvidutideN/A
2023-03-21 16:20 ESTNewsAltimmune leads obesity drug developers lower after data for lead assetN/A
2023-02-28 16:09 ESTNewsAltimmune GAAP EPS of -$0.43 beats by $0.11N/A
2023-02-28 16:07 ESTNewsAltimmune (ALT) Q4 2022 Earnings Call TranscriptN/A
2023-02-28 01:16 ESTNewsAltimmune Q4 2022 Earnings PreviewN/A
2023-02-23 11:31 ESTNewsAltimmune's Peptide-Based Therapies Offer Substantial OpportunityN/A
2023-02-21 21:15 ESTNewsAltimmune: Potential Dual Action For Pemvidutide In Obesity, NASHN/A
2022-12-21 01:07 ESTNewsAltimmune rises 5% on positive data from phase 1 trial of Non-Alcoholic Fatty Liver Disease treatmentN/A
2022-12-02 18:36 ESTNewsAltimmune Appears To Have A Winner, But Will The Market Believe?N/A
2022-12-02 01:08 ESTNewsAltimmune spikes as Goldman Sachs sees over 100% upsideN/A
2022-11-30 13:10 ESTNewsAltimmune: Weight Loss Data Signals A Costly ConfusionN/A
2022-11-11 05:50 ESTNewsAltimmune, Inc. (ALT) Q3 2022 Earnings Call TranscriptN/A
2022-11-10 12:39 ESTNewsAltimmune GAAP EPS of -$0.48 beats by $0.01N/A
2022-11-10 12:38 ESTNewsAltimmune rises 5.2% on smaller-than-expected Q3 lossN/A
2022-09-16 22:56 ESTNewsAltimmune defended at H.C. Wainwright ahead of key readout for obesity drugN/A
2022-09-15 11:25 ESTNewsAltimmune: Overreaction On NASH Data Creates Buying OpportunityN/A
2022-09-14 18:07 ESTNewsAltimmune stock slumps 56% despite drug meeting main goal of reducing liver fat in trialN/A
2022-09-14 18:07 ESTNewsPiper Sandler sees Altimmune liver/obesity drug competitive despite weight loss dataN/A
2022-09-07 13:52 ESTNewsReassessing AltimmuneN/A
2022-09-01 01:36 ESTNewsAltimmune sets new 52-week high on rising volumeN/A
2022-08-11 22:36 ESTNewsAltimmune GAAP EPS of -$0.42 beats by $0.05, revenue of $8KN/A
2022-08-11 22:36 ESTNewsAltimmune quarterly net loss narrows as it beats on the bottom lineN/A
2022-08-11 22:36 ESTNewsAltimmune, Inc. (ALT) CEO Vipin Garg on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-11 05:48 ESTNewsAltimmune Q2 2022 Earnings PreviewN/A
2022-06-29 11:28 ESTNewsAltimmune: Several Catalysts In 2 Large Market Indications This YearN/A
2022-05-13 06:49 ESTNewsAltimmune, Inc. (ALT) CEO Vipin K. Garg on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-12 12:17 ESTNewsAltimmune GAAP EPS of -$0.44 beats by $0.14, revenue of $0.03M misses by $0.85MN/A
2022-05-11 18:31 ESTNewsAltimmune Q1 2022 Earnings PreviewN/A
2022-04-07 19:53 ESTNewsAltimmune's New Avatar As A Liver Disease PlayerN/A
2022-04-01 18:50 ESTNewsAltimmune begins enrollment in phase 2 trial of pemvidutide to treat obesityN/A
2022-03-15 16:28 ESTNewsAltimmune GAAP EPS of -$0.57 beats by $0.08, revenue of $3.28M beats by $3.19MN/A
2022-03-15 16:28 ESTNewsAltimmune stock falls ~5% despite Q4 beatN/A
2022-03-15 16:28 ESTNewsAltimmune, Inc. (ALT) CEO Vipin Garg on Q4 2021 Results - Earnings Call TranscriptN/A
2022-01-31 13:06 ESTNewsFDA clears Altimmune's pemvidutide application for obesityN/A
2022-01-03 16:07 ESTNewsAltimmune: Changing Focus To Pemvidutide In 2022N/A
2021-12-13 14:56 ESTNewsNew finance chief at AltimmuneN/A
2021-11-23 16:46 ESTNewsWarning: ALT is at high risk of performing badlyN/A
2021-11-22 18:32 ESTNewsAltimmune (ALT) Presents At 2021 Virtual Healthcare Conference - SlideshowN/A
2021-11-11 20:59 ESTNewsAltimmune, Inc.'s (ALT) CEO Vipin Garg on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-11 00:44 ESTNewsAltimmune EPS misses by $0.38, beats on revenueN/A
2021-11-11 00:43 ESTNewsAltimmune, Inc. (ALT) CEO Vipin Garg on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-10 02:01 ESTNewsAltimmune Q3 2021 Earnings PreviewN/A
2021-10-16 20:22 ESTNewsAltimmune: Changing The ThesisN/A
2021-10-04 22:54 ESTNewsAltimmune initiates Phase 1b trial of pemvidutide in non-alcoholic fatty liver diseaseN/A
2021-09-28 11:25 ESTNewsAltimmune spikes on data readout for obesity therapy tomorrowN/A
2021-09-28 11:25 ESTNewsAltimmune slips after posting 12-week data from Phase 1 trial for weight loss therapyN/A

About Altimmune, Inc (ALT):

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing intranasal vaccines, immune modulating therapies, and treatments for liver disease. The company develops AdCOVID, a single-dose intranasal vaccine that is in Phase I clinical trial to protect against COVID-19; T-COVID, an intranasal immune modulating therapeutic candidate, which is in Phase I/II clinical trial to evaluate the potential of T-COVID to prevent clinical worsening in patients with early COVID-19; NasoShield, an anthrax vaccine product candidate that is in a Phase 1b trial; and NasoVAX, a recombinant intranasal vaccine product candidate, which completed Phase IIa clinical trial for the treatment of seasonal and pandemic use. It also focuses on developing ALT-801, a novel peptide-based dual GLP-1/glucagon receptor agonist for the treatment of non-alcoholic steatohepatitis that is in Phase I clinical trial; and HepTcell, an immunotherapeutic product candidate, which is in Phase II clinical trial for patients chronically infected with the hepatitis B virus. Altimmune, Inc. has a collaboration with the University of Alabama at Birmingham for the development of AdCOVID. The company is headquartered in Gaithersburg, Maryland.

ALT Quotes by TradingView

See Advanced Chart

General

  • Name Altimmune, Inc
  • Symbol ALT
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 43
  • Last Split Factor1:30
  • Last Split Date2018-09-14
  • Fiscal Year EndDecember
  • IPO Date2005-10-06
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://altimmune.com
View More

Valuation

  • Trailing PE 1.82
  • Price/Sales (Trailing 12 Mt.) 54.44
  • Price/Book (Most Recent Quarter) 2.86
  • Enterprise Value Revenue 52.73
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$2.04
  • Next Year EPS Estimate $0.70
  • Next Quarter EPS Estimate -$0.18
  • Operating Margin -471%
  • Return on Assets -16%
  • Return on Equity -36%
  • Revenue 8.19 million
  • Earnings Per Share -$4.16
  • Revenue Per Share $0.32
  • Gross Profit -25324291
  • Quarterly Earnings Growth 301.7%
View More

Highlights

  • Market Capitalization 641.59 million
  • EBITDA -11790191
  • Analyst Target Price $41.83
  • Book Value Per Share $6.11
View More

Share Statistics

  • Shares Outstanding 37.15 million
  • Shares Float 29.2 million
  • % Held by Insiders 651%
  • % Held by Institutions 67.3%
  • Shares Short 2.41 million
  • Shares Short Prior Month 2.52 million
  • Short Ratio 1.22
  • Short % of Float 8%
  • Short % of Shares Outstanding 7%
View More

Technicals

  • Beta 1.37
  • 52 Week High $35.1
  • 52 Week Low $2.68
  • 50 Day Moving Average 17.82
  • 200 Day Moving Average 13.78
View More

Dividends

  • Dividend Date 2018-09-14
  • ExDividend Date 2017-01-20
  • Dividend Yield 0%
View More

Altimmune, Inc (ALT) Dividend Calendar:

ALT's last dividend payment was made to shareholders on September 14, 2018.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Altimmune, Inc (ALT) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$2.31 million-$0.17-$0.8078.84%
2020-09-302020-11-09$2.94 million-$0.54-$0.7628.95%
2020-06-302020-08-11$N/A-$0.94-$0.29-229.82%
2020-03-312020-05-13$2.21 million-$0.26-$0.3218.75%
2019-12-312020-03-27$N/A-$0.25-$0.263.85%
2019-09-302019-11-13$643978-$0.74-$0.19-289.47%
2019-06-302019-08-13$1.63 million-$0.26-$0.25-4%
2019-03-312019-04-01$2.96 million-$0.27-$2.8090.36%
2018-12-312019-03-31$2.59 million-$2.34-$2.8016.43%
2018-09-302018-11-13$2.63 million-$1.73-$3.6051.94%
2018-06-302018-08-14$2.42 million-$10.20-$4.50-126.67%
2018-03-312018-05-15$2.69 million-$8.73-$15.0041.78%
2017-12-312018-03-28$2.3 million-$2.40-$15.0084%
2017-09-302017-11-09$4.59 million-$10.20-$8.40-21.43%
2017-06-302017-08-10$3.04 million-$7.73
2014-09-302014-11-06$962451-$24.00-$7.50-220%
2014-06-302014-08-04$3.66 million-$3.00-$16.5081.82%
2014-03-312014-05-08$3.74 million-$12.00-$18.0033.33%
2013-12-312014-03-11$3.65 million-$24.00-$15.00-60%
2013-09-302013-11-07$3.49 million-$24.00-$10.50-128.57%
2013-06-302013-08-07$4.3 million-$6.00-$9.0033.33%
2013-03-312013-05-08$6.48 million-$12.00-$15.0020%
2012-12-312013-03-13$6.01 million-$6.00-$12.0050%
2012-09-302012-11-06$6.7 million-$1.33-$9.0085.25%
2012-06-302012-08-07$6.32 million-$6.00-$9.0033.33%
2012-03-312012-05-08$6.15 million-$18.00-$15.00-20%
2011-12-312012-03-08$3.00-$32.00109.38%
2011-09-302011-11-09$5.26 million-$0.21-$25.0099.17%
2011-06-302011-08-10$6.43 million-$15.00-$31.5052.38%
2011-03-312011-05-11-$12.00-$29.0058.62%
2010-12-312011-03-28-$138.00-$26.00-430.77%
2010-09-302010-11-11-$42.00-$52.0019.23%
2010-06-302010-08-12-$66.00-$61.50-7.32%
2010-03-312010-05-11-$84.00-$51.00-64.71%
2009-12-312010-03-23-$60.00-$61.502.44%
2009-09-302009-11-12-$150.00-$57.00-163.16%
2009-06-302009-08-13-$72.00-$54.00-33.33%
2009-03-312009-05-15-$69.00-$60.00-15%
2008-12-312009-03-30-$51.00-$78.0034.62%
2008-09-302008-11-13-$60.00-$78.0023.08%
2008-06-302008-08-13-$296.82
2008-03-312008-05-14-$68.15
2007-09-302007-11-13-$20.56
2007-03-312007-03-31$7.48
2006-12-312006-12-31-$11,895.61
2006-09-302006-09-30$6.64
2006-06-302006-06-30$6.11
2006-03-312006-03-31$4.47
2005-12-312005-12-31$4.81

Altimmune, Inc (ALT) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Altimmune, Inc (ALT) Chart:

Altimmune, Inc (ALT) News:

Below you will find a list of latest news for Altimmune, Inc (ALT) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Altimmune, Inc (ALT) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-04-240.52.98CALL2 1210TRUE2.980
2026-04-2412.42CALL8 180TRUE0.090.04
2026-04-241.50CALL0 140TRUE00
2026-04-2420CALL0 2940.92TRUE00
2026-04-242.50CALL0 0911.44TRUE00
2026-04-2430.41CALL3 160TRUE-0.1-0.2
2026-04-243.50.14CALL190 31289.38TRUE-0.01-0.07
2026-04-2440.01CALL1 19584.13FALSE-0.04-0.8
2026-04-244.50CALL0 21202.72FALSE00
2026-04-2450.03CALL4 34227.52FALSE0.030
2026-04-245.50CALL0 0367.46FALSE00
2026-04-2460.05CALL0 4298.62FALSE00
2026-04-246.50.02CALL0 2381.73FALSE00
2026-04-2470CALL0 0414.26FALSE00
2026-04-247.50.05CALL2 1443.81FALSE-0.3-0.86
2026-04-2480CALL0 0470.86FALSE00
2026-04-248.50CALL0 0495.81FALSE00
2026-04-240.50.02PUT30 01051.03FALSE0.020
2026-04-2410PUT0 0710.46FALSE00
2026-04-241.50PUT0 0496.56FALSE00
2026-04-2420PUT0 0346.58FALSE00
2026-04-242.50PUT0 0274.9FALSE00
2026-04-2430.02PUT0 30158.21FALSE00
2026-04-243.50.05PUT1176 6935.95FALSE-0.1-0.67
2026-04-2440.64PUT13 360TRUE0.640
2026-04-244.51.12PUT1 2279.12TRUE0.120.12
2026-04-2451.54PUT2 0252.82TRUE1.540
2026-04-245.52.02PUT1 0263.85TRUE2.020
2026-04-2462.53PUT5 7322.37TRUE0.10.04
2026-04-246.53.05PUT5 2392.79TRUE0.120.04
2026-04-2473.48PUT2 20TRUE0.060.02
2026-04-247.53.74PUT1 2320.15TRUE-0.2-0.05
2026-04-2484.55PUT3 0484.17TRUE0.10.02
2026-04-248.54.97PUT2 00TRUE4.970
2026-05-010.52.8CALL0 5490TRUE00
2026-05-0112.65CALL2 24715.91TRUE2.650
2026-05-011.52CALL0 71022.89TRUE00
2026-05-0121.38CALL0 2754.06TRUE00
2026-05-012.50CALL0 0566.84TRUE00
2026-05-0130.6CALL60 469137.82TRUE0.10.2
2026-05-013.50.22CALL65 504102.07TRUE0.220
2026-05-0140.05CALL166 270090.26FALSE00
2026-05-014.50.05CALL2 6131.06FALSE0.050
2026-05-0150CALL0 14256.37FALSE00
2026-05-015.50.05CALL0 1290.14FALSE00
2026-05-0160.73CALL0 7187.35FALSE00
2026-05-016.50.35CALL0 4345.1FALSE00
2026-05-0170CALL0 0395.93FALSE00
2026-05-017.50.3CALL1 1300.59FALSE0.30
2026-05-010.50PUT0 2656.48FALSE00
2026-05-0110.03PUT1 3438.21FALSE0.030
2026-05-011.50PUT0 0900.6FALSE00
2026-05-0120.03PUT0 1678.42FALSE00
2026-05-012.50.08PUT0 0372.78FALSE00
2026-05-0130.05PUT0 3866.8FALSE00
2026-05-013.50.29PUT0 917.39FALSE00
2026-05-0140.6PUT1 1661.78TRUE0.020.03
2026-05-014.51.12PUT1 3118.03TRUE1.120
2026-05-0151.47PUT0 10TRUE00
2026-05-015.52.1PUT7 0148.13TRUE0.130.07
2026-05-0162.55PUT0 0170.13TRUE00
2026-05-016.53.32PUT0 30TRUE00
2026-05-0173.8PUT0 1208.29TRUE00
2026-05-017.53.97PUT0 0593.15TRUE00
2026-05-080.53.15CALL0 900TRUE00
2026-05-0812.69CALL0 70TRUE00
2026-05-081.51.87CALL0 8841.42TRUE00
2026-05-0820CALL0 00TRUE00
2026-05-082.51.05CALL15 26430.9TRUE1.050
2026-05-0830.5CALL0 30TRUE00
2026-05-083.50.2CALL12 10682.56TRUE-0.04-0.17
2026-05-0840.07CALL34 29187.09FALSE-0.03-0.3
2026-05-084.50CALL0 0167.88FALSE00
2026-05-0850CALL0 0198.5FALSE00
2026-05-085.50.75CALL0 1224.26FALSE00
2026-05-0860CALL0 0566.71FALSE00
2026-05-086.50CALL0 0429.02FALSE00
2026-05-0870CALL0 0317.95FALSE00
2026-05-080.50.01PUT0 7508.56FALSE00
2026-05-0810PUT0 1324.87FALSE00
2026-05-081.50PUT0 0697.44FALSE00
2026-05-0820PUT0 0395.05FALSE00
2026-05-082.50PUT0 0282.52FALSE00
2026-05-0830.13PUT0 8469.69FALSE00
2026-05-083.50.26PUT0 2126.57FALSE00
2026-05-0840.64PUT12 50TRUE0.640
2026-05-084.51.08PUT1 20TRUE1.080
2026-05-0851.6PUT1 10TRUE0.130.09
2026-05-085.50PUT0 00TRUE00
2026-05-0862.51PUT0 10TRUE00
2026-05-086.52.88PUT0 10TRUE00
2026-05-0870PUT0 00TRUE00
2026-05-150.50CALL0 00TRUE00
2026-05-1510CALL0 10TRUE00
2026-05-151.50CALL0 0392.46TRUE00
2026-05-1521.6CALL0 20371.04TRUE00
2026-05-152.50CALL0 00TRUE00
2026-05-1530.68CALL0 124125.42TRUE00
2026-05-153.50.3CALL228 0107.99TRUE0.30
2026-05-1540.15CALL134 1732108.84FALSE0.050.5
2026-05-154.50.07CALL2 0107.98FALSE0.070
2026-05-1550.05CALL4 306119.6FALSE0.050
2026-05-155.50CALL0 0196.99FALSE00
2026-05-1560CALL0 51169.61FALSE00
2026-05-156.50CALL0 0232.49FALSE00
2026-05-1570CALL0 5158.78FALSE00
2026-05-150.50PUT0 00FALSE00
2026-05-1510PUT0 0271.35FALSE00
2026-05-151.50PUT0 0456.72FALSE00
2026-05-1520PUT0 0473.64FALSE00
2026-05-152.50PUT0 0232.01FALSE00
2026-05-1530PUT0 8359.84FALSE00
2026-05-153.50.35PUT5 00FALSE0.350
2026-05-1540.7PUT0 850TRUE00
2026-05-154.50PUT0 00TRUE00
2026-05-1550PUT0 00TRUE00
2026-05-155.50PUT0 00TRUE00
2026-05-1560PUT0 10TRUE00
2026-05-156.50PUT0 00TRUE00
2026-05-1570PUT0 10TRUE00
2026-05-220.53.1CALL0 170TRUE00
2026-05-2210CALL0 1484.85TRUE00
2026-05-221.50CALL0 1481.29TRUE00
2026-05-2220CALL0 0356.07TRUE00
2026-05-222.50CALL0 0170.06TRUE00
2026-05-2230CALL0 1153.92TRUE00
2026-05-223.50.35CALL0 124115.87TRUE00
2026-05-2240.15CALL10 4101.94FALSE0.150
2026-05-224.50CALL0 0195.86FALSE00
2026-05-2250.1CALL0 41110.32FALSE00
2026-05-225.50.05CALL0 1241.55FALSE00
2026-05-2260CALL0 2259.63FALSE00
2026-05-226.50.35CALL1 2268.23FALSE0.350
2026-05-220.50PUT0 00FALSE00
2026-05-2210PUT0 0766.63FALSE00
2026-05-221.50PUT0 0513.04FALSE00
2026-05-2220PUT0 1326.97FALSE00
2026-05-222.50PUT0 0266.15FALSE00
2026-05-2230.15PUT0 13102.03FALSE00
2026-05-223.50.35PUT2 50FALSE0.050.17
2026-05-2240PUT0 10TRUE00
2026-05-224.51.14PUT2 00TRUE1.140
2026-05-2250PUT0 00TRUE00
2026-05-225.50PUT0 077.33TRUE00
2026-05-2260PUT0 10TRUE00
2026-05-226.53.04PUT2 10TRUE3.040
2026-05-290.50CALL0 00TRUE00
2026-05-2912.6CALL5 0433.94TRUE2.60
2026-05-291.50CALL0 10TRUE00
2026-05-2920CALL0 0326.82TRUE00
2026-05-292.50CALL0 0341.34TRUE00
2026-05-2930CALL0 1224.86TRUE00
2026-05-293.50.35CALL93 1111.04TRUE0.350
2026-05-2940.2CALL0 4111.16FALSE00
2026-05-294.50CALL0 1202.46FALSE00
2026-05-2950CALL0 2383.32FALSE00
2026-05-295.50.26CALL0 41250.65FALSE00
2026-05-2960CALL0 0292.28FALSE00
2026-05-296.50.1CALL0 2380.04FALSE00
2026-05-2970.1CALL0 2314.19FALSE00
2026-05-290.50PUT0 00FALSE00
2026-05-2910PUT0 00FALSE00
2026-05-291.50PUT0 0356.19FALSE00
2026-05-2920PUT0 0540.04FALSE00
2026-05-292.50PUT0 0406.08FALSE00
2026-05-2930.2PUT0 845.4FALSE00
2026-05-293.50PUT0 00FALSE00
2026-05-2940PUT0 10TRUE00
2026-05-294.50PUT0 0149.08TRUE00
2026-05-2950PUT0 10TRUE00
2026-05-295.50PUT0 00TRUE00
2026-05-2960PUT0 10TRUE00
2026-05-296.50PUT0 00TRUE00
2026-05-2970PUT0 00TRUE00
2026-06-1810CALL0 32567.54TRUE00
2026-06-1821.55CALL0 400TRUE00
2026-06-1830.95CALL100 484142.72TRUE0.950
2026-06-1840.3CALL23 3337124.52FALSE0.020.07
2026-06-1850.13CALL319 5230121.5FALSE-0.02-0.13
2026-06-1860.09CALL137 4044133.07FALSE00
2026-06-1870.05CALL41 2669133.61FALSE00
2026-06-1880.06CALL18 805153.5FALSE0.060
2026-06-1890.05CALL100 456160.4FALSE00
2026-06-18100.05CALL24 14329171.13FALSE0.050
2026-06-1810PUT0 1191.7FALSE00
2026-06-1820.05PUT0 16199.8FALSE00
2026-06-1830.25PUT0 26412.11FALSE00
2026-06-1840.72PUT3 15600TRUE-0.03-0.04
2026-06-1850PUT0 13930TRUE00
2026-06-1862.5PUT100 13040TRUE2.50
2026-06-1870PUT0 1010TRUE00
2026-06-1880PUT0 60TRUE00
2026-06-1890PUT0 10TRUE00
2026-06-18100PUT0 10TRUE00
2026-09-1812.5CALL1 52480.97TRUE-0.1-0.04
2026-09-1821.65CALL1 73208.8TRUE1.650
2026-09-1831.02CALL1 291178.63TRUE0.040.04
2026-09-1840.6CALL2 744157.72FALSE-0.05-0.08
2026-09-1850.37CALL61 795148.35FALSE-0.03-0.08
2026-09-1860.35CALL0 482154.64FALSE00
2026-09-1870.21CALL2 535150.89FALSE0.210
2026-09-1880.15CALL0 416153.96FALSE00
2026-09-1890.15CALL0 17220.53FALSE00
2026-09-18100.14CALL0 197170.58FALSE00
2026-09-1810PUT0 0229.57FALSE00
2026-09-1820PUT0 073.51FALSE00
2026-09-1830.54PUT0 1100FALSE00
2026-09-1841PUT0 2780TRUE00
2026-09-1850PUT0 890TRUE00
2026-09-1863.26PUT0 180TRUE00
2026-09-1870PUT0 280TRUE00
2026-09-1880PUT0 10TRUE00
2026-09-1890PUT0 20TRUE00
2026-09-18100PUT0 00TRUE00
2026-12-1810CALL0 00TRUE00
2026-12-1820CALL0 0209.12TRUE00
2026-12-1830CALL0 0198.21TRUE00
2026-12-1840CALL0 0186.63FALSE00
2026-12-1850CALL0 0251.48FALSE00
2026-12-1860CALL0 0201.94FALSE00
2026-12-1810PUT0 0229.21FALSE00
2026-12-1820PUT0 00FALSE00
2026-12-1830.58PUT7 70FALSE-0.01-0.02
2026-12-1840PUT0 00TRUE00
2026-12-1850PUT0 00TRUE00
2026-12-1860PUT0 00TRUE00
2027-01-1512.5CALL0 177362.89TRUE00
2027-01-1520CALL0 2551258.42TRUE00
2027-01-1531.3CALL16 2273218.39TRUE0.10.08
2027-01-1540.98CALL101 3272203.95FALSE0.060.07
2027-01-1550.76CALL45 7051196.07FALSE0.010.01
2027-01-1560.71CALL7 0204.51FALSE0.710
2027-01-1570.5CALL3 5207186.6FALSE0.50
2027-01-15100.45CALL11 9198203.09FALSE0.060.15
2027-01-15120.29CALL11 1345187.46FALSE0.020.07
2027-01-15150.25CALL1 1696192.06FALSE0.250
2027-01-15170.28CALL6 2854188.18FALSE0.020.08
2027-01-15200.2CALL0 15938190.42FALSE00
2027-01-1510PUT0 00FALSE00
2027-01-1520PUT0 3630FALSE00
2027-01-1530.65PUT0 3620FALSE00
2027-01-1541.33PUT1 13050TRUE1.330
2027-01-1550PUT0 11190TRUE00
2027-01-1560PUT0 00TRUE00
2027-01-1570PUT0 5900TRUE00
2027-01-15100PUT0 4690TRUE00
2027-01-15120PUT0 790TRUE00
2027-01-15150PUT0 2310TRUE00
2027-01-15170PUT0 1300TRUE00
2027-01-15200PUT0 280TRUE00
2028-01-2112.77CALL4 57475.07TRUE2.770
2028-01-2122.17CALL0 68517.25TRUE00
2028-01-2131.9CALL3 605329.6TRUE00
2028-01-2141.44CALL1 58268.14FALSE1.440
2028-01-2151.37CALL0 371395.48FALSE00
2028-01-2171.19CALL0 857269.91FALSE00
2028-01-21100.94CALL14 1744262.35FALSE0.090.11
2028-01-2110PUT0 00FALSE00
2028-01-2120PUT0 00FALSE00
2028-01-2130PUT0 250FALSE00
2028-01-2140PUT0 160TRUE00
2028-01-2150PUT0 430TRUE00
2028-01-2170PUT0 380TRUE00
2028-01-21100PUT0 420TRUE00

Latest ALT Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST1$9.25
Jun 13, 2022 7:59 PM EST399$9.25
Jun 13, 2022 7:59 PM EST58$9.25
Jun 13, 2022 7:59 PM EST100$9.25
Jun 13, 2022 7:59 PM EST200$9.235

Altimmune, Inc (ALT) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320018161/0000899243-20-018161-index.htm
2019-04-15UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1326190/000000000019007165/0000000000-19-007165-index.htm
2019-08-16UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1326190/000000000019012559/0000000000-19-012559-index.htm
2019-08-22UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1326190/000000000019012749/0000000000-19-012749-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924319016650/0000899243-19-016650-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924319017407/0000899243-19-017407-index.htm
2019-09-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924319022846/0000899243-19-022846-index.htm
2019-09-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924319023316/0000899243-19-023316-index.htm
2019-09-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924319023318/0000899243-19-023318-index.htm
2019-12-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924319028409/0000899243-19-028409-index.htm
2020-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320000074/0000899243-20-000074-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320000275/0000899243-20-000275-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320000276/0000899243-20-000276-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320000279/0000899243-20-000279-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320000286/0000899243-20-000286-index.htm
2020-02-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320002630/0000899243-20-002630-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320002960/0000899243-20-002960-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320002986/0000899243-20-002986-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320003006/0000899243-20-003006-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320006772/0000899243-20-006772-index.htm
2020-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320009897/0000899243-20-009897-index.htm
2020-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320011911/0000899243-20-011911-index.htm
2020-05-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320012836/0000899243-20-012836-index.htm
2020-05-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320012840/0000899243-20-012840-index.htm
2020-05-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320013395/0000899243-20-013395-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320014937/0000899243-20-014937-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320017823/0000899243-20-017823-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320017824/0000899243-20-017824-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320017826/0000899243-20-017826-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320017831/0000899243-20-017831-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320017833/0000899243-20-017833-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320017835/0000899243-20-017835-index.htm
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320018161/0000899243-20-018161-index.htm
2020-08-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320021020/0000899243-20-021020-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320021205/0000899243-20-021205-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320021207/0000899243-20-021207-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320021212/0000899243-20-021212-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320021219/0000899243-20-021219-index.htm
2020-08-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320023683/0000899243-20-023683-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320026409/0000899243-20-026409-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320026410/0000899243-20-026410-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320026411/0000899243-20-026411-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320026412/0000899243-20-026412-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320026413/0000899243-20-026413-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320026414/0000899243-20-026414-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320026415/0000899243-20-026415-index.htm
2020-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320026921/0000899243-20-026921-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320028535/0000899243-20-028535-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320028536/0000899243-20-028536-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320028537/0000899243-20-028537-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320028538/0000899243-20-028538-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320028539/0000899243-20-028539-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320028540/0000899243-20-028540-index.htm
2020-11-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320030113/0000899243-20-030113-index.htm
2019-03-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000092542119000135/0000925421-19-000135-index.htm
2019-03-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000092542119000137/0000925421-19-000137-index.htm
2018-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297518001065/0001012975-18-001065-index.htm
2018-10-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297518001091/0001012975-18-001091-index.htm
2018-10-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297518001100/0001012975-18-001100-index.htm
2018-12-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297518001271/0001012975-18-001271-index.htm
2018-12-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297518001273/0001012975-18-001273-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000028/0001012975-19-000028-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000029/0001012975-19-000029-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000031/0001012975-19-000031-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000033/0001012975-19-000033-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000035/0001012975-19-000035-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000037/0001012975-19-000037-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000039/0001012975-19-000039-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000041/0001012975-19-000041-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000043/0001012975-19-000043-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000106823820000055/0001068238-20-000055-index.htm
2018-10-05SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000110465918060692/0001104659-18-060692-index.htm
2019-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000110465919005825/0001104659-19-005825-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000110465919008563/0001104659-19-008563-index.htm
2020-06-01SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000110465920068336/0001104659-20-068336-index.htm
2020-06-25SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1326190/000110465920076855/0001104659-20-076855-index.htm
2020-09-24SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000110465920108310/0001104659-20-108310-index.htm
2020-10-05SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000110465920112175/0001104659-20-112175-index.htm
2018-09-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518280602/0001193125-18-280602-index.htm
2018-09-24424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1326190/000119312518280966/0001193125-18-280966-index.htm
2018-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518281668/0001193125-18-281668-index.htm
2018-09-26S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1326190/000119312518284095/0001193125-18-284095-index.htm
2018-09-27CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1326190/000119312518285764/0001193125-18-285764-index.htm
2018-09-27CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1326190/000119312518285783/0001193125-18-285783-index.htm
2018-09-28POS EXPost-effective amendment adding exhibits to registration statement [Rule 462(d)]https://www.sec.gov/Archives/edgar/data/1326190/000119312518286447/0001193125-18-286447-index.htm
2018-10-01424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1326190/000119312518289729/0001193125-18-289729-index.htm
2018-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518289763/0001193125-18-289763-index.htm
2018-10-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000119312518293265/0001193125-18-293265-index.htm
2018-10-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518295412/0001193125-18-295412-index.htm
2018-10-09424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1326190/000119312518295424/0001193125-18-295424-index.htm
2018-10-09424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1326190/000119312518296082/0001193125-18-296082-index.htm
2018-10-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518304261/0001193125-18-304261-index.htm
2018-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518325584/0001193125-18-325584-index.htm
2018-11-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1326190/000119312518325587/0001193125-18-325587-index.htm
2018-11-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518335258/0001193125-18-335258-index.htm
2018-11-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518339667/0001193125-18-339667-index.htm
2018-11-30S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1326190/000119312518339756/0001193125-18-339756-index.htm
2018-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518340078/0001193125-18-340078-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000119312519033928/0001193125-19-033928-index.htm
2019-03-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519067835/0001193125-19-067835-index.htm
2019-03-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519070141/0001193125-19-070141-index.htm
2019-03-11424B2Prospectus [Rule 424(b)(2)]https://www.sec.gov/Archives/edgar/data/1326190/000119312519070146/0001193125-19-070146-index.htm
2019-03-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519076851/0001193125-19-076851-index.htm
2019-04-04S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1326190/000119312519097986/0001193125-19-097986-index.htm
2019-04-04S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1326190/000119312519097996/0001193125-19-097996-index.htm
2019-04-11CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1326190/000119312519103831/0001193125-19-103831-index.htm
2019-04-11CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1326190/000119312519104131/0001193125-19-104131-index.htm
2019-06-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519168149/0001193125-19-168149-index.htm
2019-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519171212/0001193125-19-171212-index.htm
2019-06-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519178904/0001193125-19-178904-index.htm
2019-07-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519190926/0001193125-19-190926-index.htm
2019-07-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519193586/0001193125-19-193586-index.htm
2019-08-09PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1326190/000119312519218069/0001193125-19-218069-index.htm
2019-08-14S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1326190/000119312519221188/0001193125-19-221188-index.htm
2019-08-19CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1326190/000119312519224352/0001193125-19-224352-index.htm
2019-08-19PRER14APreliminary Proxy Soliciting materialshttps://www.sec.gov/Archives/edgar/data/1326190/000119312519224357/0001193125-19-224357-index.htm
2019-08-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519225595/0001193125-19-225595-index.htm
2019-08-22DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1326190/000119312519226618/0001193125-19-226618-index.htm
2019-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519259847/0001193125-19-259847-index.htm
2020-03-27424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1326190/000119312520087649/0001193125-20-087649-index.htm
2020-03-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312520088680/0001193125-20-088680-index.htm
2020-04-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312520100902/0001193125-20-100902-index.htm
2020-05-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312520139801/0001193125-20-139801-index.htm
2020-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312520156447/0001193125-20-156447-index.htm
2020-06-01424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1326190/000119312520156472/0001193125-20-156472-index.htm
2020-07-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312520191485/0001193125-20-191485-index.htm
2020-07-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1326190/000119312520191866/0001193125-20-191866-index.htm
2020-07-15424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1326190/000119312520192791/0001193125-20-192791-index.htm
2020-07-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312520194024/0001193125-20-194024-index.htm
2020-07-168-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312520194052/0001193125-20-194052-index.htm
2020-08-21DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1326190/000119312520226963/0001193125-20-226963-index.htm
2020-08-21S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1326190/000119312520226971/0001193125-20-226971-index.htm
2020-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312520254566/0001193125-20-254566-index.htm
2020-02-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000120919120009672/0001209191-20-009672-index.htm
2018-10-17SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000121390018014006/0001213900-18-014006-index.htm
2019-02-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000121390019001904/0001213900-19-001904-index.htm
2020-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000121390020003212/0001213900-20-003212-index.htm
2019-02-01SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000139382519000035/0001393825-19-000035-index.htm
2020-01-31SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000139382520000012/0001393825-20-000012-index.htm
2019-04-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1326190/000156459019010429/0001564590-19-010429-index.htm
2019-04-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000156459019010435/0001564590-19-010435-index.htm
2019-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1326190/000156459019019139/0001564590-19-019139-index.htm
2019-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000156459019019146/0001564590-19-019146-index.htm
2019-08-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1326190/000156459019031795/0001564590-19-031795-index.htm
2019-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000156459019031811/0001564590-19-031811-index.htm
2019-11-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1326190/000156459019043231/0001564590-19-043231-index.htm
2019-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000156459019043240/0001564590-19-043240-index.htm
2020-03-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000156459020013376/0001564590-20-013376-index.htm
2020-03-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1326190/000156459020013377/0001564590-20-013377-index.htm
2020-05-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1326190/000156459020025123/0001564590-20-025123-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000156459020025137/0001564590-20-025137-index.htm
2020-08-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000156459020039298/0001564590-20-039298-index.htm
2020-08-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1326190/000156459020039314/0001564590-20-039314-index.htm
2020-05-283Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000173804820000001/0001738048-20-000001-index.htm
2020-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000173804820000003/0001738048-20-000003-index.htm
2018-09-27EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1326190/999999999518002478/9999999995-18-002478-index.htm
2019-04-12EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1326190/999999999519000701/9999999995-19-000701-index.htm
2018-10-04CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1326190/999999999718008376/9999999997-18-008376-index.htm

Altimmune, Inc (ALT) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Altimmune, Inc (ALT). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 651%
Institutional Ownership: 6730%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-07-31William Michael BrownChief Financial OfficerBuy7,920.001.4611,563.2015,981.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320021212/0000899243-20-021212-index.htm
2020-05-15VELOCITY PHARMACEUTICAL HOLDINGS LLC10% Share HolderSell30,622.004.65142,392.301,687,250.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320013395/0000899243-20-013395-index.htm
2020-05-14VELOCITY PHARMACEUTICAL HOLDINGS LLC10% Share HolderSell169,378.004.81814,708.181,717,872.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320013395/0000899243-20-013395-index.htm
2018-10-09Wayne PisanoDirectorBuy2,000.004.599,180.002,000.00https://www.sec.gov/Archives/edgar/data/1326190/000101297518001100/0001012975-18-001100-index.htm
2020-05-26Venrock Healthcare Capital Partners III, L.P.10% Share HolderBuy309,453.008.792,720,091.872,005,817.00https://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm
2020-05-26Venrock Healthcare Capital Partners III, L.P.10% Share HolderBuy390,547.009.783,819,549.662,396,364.00https://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm
2020-05-27Venrock Healthcare Capital Partners III, L.P.10% Share HolderBuy125,162.007.23904,921.262,521,526.00https://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm
2020-05-27Venrock Healthcare Capital Partners III, L.P.10% Share HolderBuy277,000.007.922,193,840.002,798,526.00https://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm
2020-05-28Venrock Healthcare Capital Partners III, L.P.10% Share HolderBuy27,763.007.79216,273.772,826,289.00https://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm
2020-05-28Venrock Healthcare Capital Partners III, L.P.10% Share HolderBuy173,711.008.871,540,816.573,000,000.00https://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm
2018-11-30Vipin K GargPresident and CEOBuy322,907.00322,907.00https://www.sec.gov/Archives/edgar/data/1326190/000101297518001273/0001012975-18-001273-index.htm
2020-07-31Vipin K GargChief Financial OfficerBuy11,674.001.4617,044.04325,789.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320021205/0000899243-20-021205-index.htm
2020-01-31Vipin K GargPresident and CEOBuy11,289.001.4616,481.94326,206.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320002986/0000899243-20-002986-index.htm
2019-09-05Vipin K GargPresident and CEOBuy20,000.002.1042,000.00342,907.00https://www.sec.gov/Archives/edgar/data/1326190/000089924319022846/0000899243-19-022846-index.htm
2020-06-15Venrock Healthcare Capital Partners III, L.P.10% Share HolderBuy1,500,000.007.5411,310,000.004,500,000.00https://www.sec.gov/Archives/edgar/data/1326190/000173804820000003/0001738048-20-000003-index.htm
2020-01-31M Scot RobertsChief Scientific OfficerBuy3,698.001.465,399.085,535.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320002960/0000899243-20-002960-index.htm
2020-01-31William Michael BrownChief Financial OfficerBuy8,061.001.4611,769.068,061.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320003006/0000899243-20-003006-index.htm
2020-07-31Matthew Scott HarrisChief Medical OfficerBuy8,084.001.4611,802.648,084.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320021219/0000899243-20-021219-index.htm
2020-07-31M Scot RobertsChief Scientific OfficerBuy3,859.001.465,634.149,394.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320021207/0000899243-20-021207-index.htm